PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20734355-6	2010	Mechanistically, GMSC treatment mitigated local inflammation mediated by a suppressed infiltration of inflammatory cells and production of IL-6 and TNF-alpha, and an increased expression of IL-10.	gmsc	17-21	interleukin 6	Homo sapiens	139-143	
33582592-9	2021	The GMSC-Exos group showed lower Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-6 (IL-6), Interleukin-1beta (IL-1beta), and cluster of differentiation 86 (CD86) expression levels than the high-lipid group, and the highest levels of Interleukin-10 (IL-10) among all groups.	gmsc	4-8	interleukin 6	Homo sapiens	74-87	
33582592-9	2021	The GMSC-Exos group showed lower Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-6 (IL-6), Interleukin-1beta (IL-1beta), and cluster of differentiation 86 (CD86) expression levels than the high-lipid group, and the highest levels of Interleukin-10 (IL-10) among all groups.	gmsc	4-8	interleukin 6	Homo sapiens	89-93